Synsam AB (publ) (STO:SYNSAM)
56.90
+0.90 (1.61%)
May 7, 2026, 5:29 PM CET
Synsam AB Employees
Synsam AB had 4,771 employees as of December 31, 2025. The number of employees increased by 1,032 or 27.60% compared to the previous year.
Employees
4,771
Change
1,032
Growth
27.60%
Revenue / Employee
1.48M SEK
Profits / Employee
95.16K SEK
Market Cap
7.95B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4,771 | 1,032 | 27.60% |
| Sep 30, 2025 | 4,000 | 181 | 4.74% |
| Jun 30, 2025 | 4,000 | 0 | - |
| Mar 31, 2025 | 4,000 | 0 | - |
| Dec 31, 2024 | 3,739 | -261 | -6.53% |
| Sep 30, 2024 | 3,819 | 343 | 9.87% |
| Jun 30, 2024 | 4,000 | 0 | - |
| Mar 31, 2024 | 4,000 | 0 | - |
| Dec 31, 2023 | 4,000 | 0 | - |
| Sep 30, 2023 | 3,476 | 223 | 6.86% |
| Jun 30, 2023 | 4,000 | 912 | 29.53% |
| Mar 31, 2023 | 4,000 | 1,024 | 34.41% |
| Dec 31, 2022 | 4,000 | 1,000 | 33.33% |
| Sep 30, 2022 | 3,253 | 253 | 8.43% |
| Jun 30, 2022 | 3,088 | 573 | 22.78% |
| Mar 31, 2022 | 2,976 | 695 | 30.47% |
| Dec 31, 2021 | 3,000 | 719 | 31.52% |
| Sep 30, 2021 | 3,000 | 719 | 31.52% |
| Jun 30, 2021 | 2,515 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ambea AB | 41,118 |
| Getinge AB | 11,754 |
| Arjo AB | 7,000 |
| Swedish Orphan Biovitrum AB | 1,862 |
| Sectra AB | 1,323 |
| Dynavox Group AB | 1,056 |
| Apotea AB | 727 |
| MedCap AB | 637 |
Synsam AB News
- 2 months ago - Synsam AB Earnings Call Transcript: Q4 2025 - Transcripts
- 6 months ago - Synsam AB Earnings Call Transcript: Q3 2025 - Transcripts
- 9 months ago - Synsam AB Earnings Call Transcript: Q2 2025 - Transcripts
- 1 year ago - Synsam AB Earnings Call Transcript: Q1 2025 - Transcripts
- 1 year ago - Synsam AB Earnings Call Transcript: Q4 2024 - Transcripts
- 1 year ago - Synsam AB Earnings Call Transcript: Q3 2024 - Transcripts
- 1 year ago - Synsam AB Earnings Call Transcript: Q2 2024 - Transcripts
- 2 years ago - Synsam AB Earnings Call Transcript: Q1 2024 - Transcripts